Bulkamid Urethral Bulking System

FDA Premarket Approval P170023

Pre-market Approval Supplement Details

Approval for the bulkamid urethral bulking system. The device is indicated for urethral injection for the treatment of stress urinary incontinence (sui) due to intrinsic sphincter deficiency (isd) in adult women who have sui or stress predominant mixed incontinence.

DeviceBulkamid Urethral Bulking System
Generic NameAgent, Bulking, Injectable For Gastro-urology Use
ApplicantContura International A/S
Date Received2017-07-31
Decision Date2020-01-28
PMAP170023
SupplementS
Product CodeLNM 
Advisory CommitteeGastroenterology/Urology
Expedited ReviewNo
Combination Product No
Applicant Address Contura International A/S sydmarken 23 soeborg 2860
Summary:Summary of Safety and Effectiveness
Labeling: Labeling Labeling Part 2
Approval Order: Approval Order

Supplemental Filings

A PHP Error was encountered

Severity: Notice

Message: Undefined offset: 0

Filename: fda.report/pma_item.php

Line Number: 131

Backtrace:

File: /var/www/fda.report/pma_item.php
Line: 131
Function: _error_handler

Supplement NumberDateSupplement Type
P170023Original Filing

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.